These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28571520)

  • 1. Profiles of Elderly People Infected with HIV and Response to Antiretroviral Treatment in Burkina Faso: A Retrospective Cohort Study.
    Diallo I; Meda N; Ouédraogo S; Poda A; Hema A; Sagna Y; Sawadogo LM; Drabo YJ; Ouedraogo DD
    J Int Assoc Provid AIDS Care; 2017; 16(4):405-411. PubMed ID: 28571520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Early Mortality on Antiretroviral Treatment of Elderly People Infected with HIV in Burkina Faso.
    Ouédraogo DD; Sawadogo LM; Sagna Y; Sawadogo AB; Diallo I; Hema A; Poda A; Drabo YJ
    J Int Assoc Provid AIDS Care; 2015; 14(6):553-9. PubMed ID: 25294855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy rate and birth outcomes among women receiving antiretroviral therapy in Burkina Faso: a retrospective cohort study.
    Poda A; Hema A; Konaté A; Kaboré F; Zoungrana J; Kamboulé E; Soré I; Bado G; Ouédraogo AS; Ouédraogo M; Meda N; Sawadogo AB
    Pan Afr Med J; 2016; 23():105. PubMed ID: 27222692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation and biomedical transition of people living with HIV to antiretroviral treatment in Burkina Faso.
    Artavia-Mora L; Wagner N; Thiombiano BA; Bedi A
    Glob Public Health; 2020 May; 15(5):638-653. PubMed ID: 31916514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso: a surprising relationship.
    Penot P; Héma A; Bado G; Sombié D; Kaboré FN; Poda A; Michon C; Terzolo O; Traoré A; Slama L; Sawadogo A; Laurent C
    AIDS Care; 2018 Dec; 30(12):1502-1506. PubMed ID: 29991274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline characteristics, response to and outcome of antiretroviral therapy among patients with HIV-1, HIV-2 and dual infection in Burkina Faso.
    Harries K; Zachariah R; Manzi M; Firmenich P; Mathela R; Drabo J; Onadja G; Arnould L; Harries A
    Trans R Soc Trop Med Hyg; 2010 Feb; 104(2):154-61. PubMed ID: 19783268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes mellitus and high blood pressure over risk in HIV-infected people followed at Souro Sanou University Hospital Day Hospital, Bobo-Dioulasso 2018].
    Hema A; Poda A; Tougouma JB; Meda C; Kabore F; Zoungrana J; Kamoule E; Sore I; Bado G; Ouedraogo AS; Sawadogo AB; Millogo A
    Rev Epidemiol Sante Publique; 2021 Apr; 69(2):72-77. PubMed ID: 33563493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunovirological discordance among female sex workers who start antiretroviral therapy in Burkina Faso.
    Bazié WW; Somé DY; Traoré IT; Sanon A; Konaté I; Tassembedo S; Taofiki AO; Kania D; Ouédraogo A; Vuylsteke B; Gilbert C; Meda N; Ouédraogo AS; Nagot N
    BMC Infect Dis; 2022 Feb; 22(1):117. PubMed ID: 35114959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic disorders and cardiovascular risk factors observed in patients infected by the HIV with antiretroviral therapy in Burkina Faso].
    Bognounou R; Diendéré A; Diallo I; Tieno H; Guira O; Ouedraogo DD; Drabo YJ
    Med Trop (Mars); 2011 Dec; 71(6):626-7. PubMed ID: 22393637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bobo Dioulasso Teaching Hospital day-care hospital: a reference structure for the management of HIV infected patients in Burkina Faso].
    Fontaine C; Hema A; Kamboule E; Guiard-Schmid JB; Lescure FX; Slama L; Pialoux G; Sawadogo A
    Med Mal Infect; 2010 Jul; 40(7):393-7. PubMed ID: 19951831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaching the 'first 90': Gaps in coverage of HIV testing among people living with HIV in 16 African countries.
    Staveteig S; Croft TN; Kampa KT; Head SK
    PLoS One; 2017; 12(10):e0186316. PubMed ID: 29023510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term evolution of immunological and virological parameters in patients undergoing treatments for HIV-1 infection at the Day Hospital of Bobo-Dioulasso, Burkina Faso.
    Samba JJC; Sawadogo Y; Sombie HK; Kafando H; Zougmore WAMJ; Damolga M; Ouattara CA; Poda A; Ouedraogo AS
    Pan Afr Med J; 2023; 44():63. PubMed ID: 37187595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and mortality associated factors in patients infected with HIV receiving a presumptive anti-tuberculosis treatment in a tertiary level hospital in Burkina Faso.
    Diendéré EA; Badoum G; Bognounou R; Guira O; Ilboudo L; Tieno H; Diallo I; Drabo J
    AIDS Care; 2015; 27(10):1250-4. PubMed ID: 26291389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High incidence of asymptomatic myocardial ischemia in a population of HIV-infected patients in Bobo-Dioulasso, Burkina Faso].
    Tougouma JB; Yaméogo AA; Yaméogo NV; Hema A; Hien H; Kambiré Y; Poda A; Zoungrana J; Zabsonré P
    Pan Afr Med J; 2021; 38():173. PubMed ID: 33995780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking HIV prevention and care for community interventions among high-risk women in Burkina Faso--the ARNS 1222 "Yerelon" cohort.
    Konate I; Traore L; Ouedraogo A; Sanon A; Diallo R; Ouedraogo JL; Huet C; Millogo I; Andonaba JB; Mayaud P; Van de Perre P; Nagot N
    J Acquir Immune Defic Syndr; 2011 Jul; 57 Suppl 1():S50-4. PubMed ID: 21857287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexually transmitted diseases and human immunodeficiency virus infection among women with genital infections in Burkina Faso.
    Meda N; Ledru S; Fofana M; Lankoandé S; Soula G; Bazié AJ; Chiron JP
    Int J STD AIDS; 1995; 6(4):273-7. PubMed ID: 7548291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decade of follow-up and therapeutic drug monitoring in HIV-2 immunocompromised patients at St Camille and General Lamizana Military Medical Centers, Burkina Faso, West Africa.
    Sanou M; Soubeiga ST; Bationo F; Compaore TR; Zohoncon TM; Diatto GN; Ouedraogo P; Pietra V; Nagalo BM; Bisseye C; Traore RO; Simpore J
    Pak J Biol Sci; 2014 Dec; 17(12):1219-24. PubMed ID: 26027168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study.
    Tweya H; Feldacker C; Heller T; Gugsa S; Ng'ambi W; Nthala O; Kalulu M; Chiwoko J; Banda R; Makwinja A; Phiri S
    PLoS One; 2017; 12(7):e0180232. PubMed ID: 28686636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.